BCL2 and B-cell non-Hodgkin lymphoma: The recently revised World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues now acknowledges the new and provisional entity of high-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements (HGBL-DH/TH) [1].